Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom today and set a price target of $86.00. According to TipRanks, Hambright is a 4-star analyst with an average return of 8.1% and a ...

Owlet, Inc. OWLT is steadily transforming from a connected baby monitor brand into a data-driven pediatric health platform, ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and ...

Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), is pleased to announce the availability of ILUMYA (tildrakizumab) Pen, a self-administered ...

DexCom, Inc. , the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Dexcom today and set a price target of $100.00. According to TipRanks, Steed is a 4-star analyst with an average return of ...

The ‍guidance, along with comments from ​FDA Commissioner Marty Makary, adds to existing policy that classifies low-risk ...

Lingo is Abbott’s over-the-counter continuous glucose monitor (CGM) for nondiabetic people. Withings users will also be able ...

Read our live updates from CES 2026 in Las Vegas to see the latest consumer gadgetry in all of its chatbot-enabled, ...

ARLINGTON, Va., Jan. 2, 2026 /PRNewswire/ -- CES ® 2026, the world's most powerful tech event, returns to Las Vegas, January 6-9, bringing together global companies, innovative startups, industry ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...